Concord Drugs

BSE: 538965 29 Jul 2025

Healthcare

₹ 64.6

Concord Drugs Limited specializes in Pharmaceuticals within the Healthcare sector.

Concord Drugs

BSE: 538965 29 Jul 2025

Healthcare

₹ 64.6

Concord Drugs Limited specializes in Pharmaceuticals within the Healthcare sector.

Book Value

34.1

Dividend Yield

0.0%

Debt to Equity

0.5

Stock P/E

165.0

Market Cap

56.0 Cr

Concord Drugs - Share Price & Details

Market Cap

₹56.0

High /Low

67.0 / 26.1

Stock P/E

165.0

Book Value

₹34.1

Dividend Yield

0.0

ROCE

5.3

ROE

₹1.0

Face Value

10.0

PEG Ratio

-4.1

EVEBITDA

₹17.6

Debt

17.2

CMP / FCF

85.7

Debt to equity

₹0.5

NP Ann

0.34

High price all time

91.2

Piotroski score

₹6.0

Graham Number

16.2

No. Eq. Shares

1.0

Net CF

₹-0.02

Net profit

0.34

Price to book value

1.64

Interest Coverage

₹1.34

Low price all time

11.7

Industry PE

34.1

Reserves

₹24.1

Free Cash Flow

₹1.39

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.46	91.0
Triochem Products Ltd.,	3.25	-4.52	NA	-18.44	0
Concord Drugs Limited	7.99	-71.62	7.94	0.08	56.0	165.0
BACIL PHARMA LTD.	NA	NA	NA	NA	53.9	135.0
Lasa Supergenerics Limited	415.29	-142.91	391.38	-2.85	52.9	58.1

Peer Comparison Chart

About Concord Drugs

Concord Drugs Limited, with Security Code 538965, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Concord Drugs Limited (538965) vs yyy - Unprecedented market success

(24 Jul 2025)

Concord Drugs Limited (538965) vs yyy ✌️【Market Movement】✌️ Real-time market signals and stock forecasts to support smart investing.

Concord Drugs Limited (538965) to Launch New Product Line - Free Bull & Bear Market Updates

(23 Jul 2025)

Concord Drugs Limited (538965) to Launch New Product Line ✌️【Stock Observations】✌️ Our trading intelligence platform has helped members turn...

Where Could Concord Drugs Limited (538965) Be Headed - Exponential wealth increase

(23 Jul 2025)

Where Could Concord Drugs Limited (538965) Be Headed ✌️【Stock Analysis】✌️ Want better returns? We track winning stocks every day — and many...

Concord Drugs Limited (538965) Hits 52 Week High - Market-beating returns

(23 Jul 2025)

Concord Drugs Limited (538965) Hits 52 Week High ✌️【Market Focus】✌️ Expert predictions on high-growth stocks, supported by real-time market...

Can Concord Drugs Limited (538965) Maintain Its Valuation - Superior risk-adjusted returns

(21 Jul 2025)

Can Concord Drugs Limited (538965) Maintain Its Valuation ✌️【Investor Trends】✌️ Discover breakout opportunities in emerging markets,...

Concord Drugs Limited (538965) to Launch New Product Line - Free Wealth Planning Blueprint

(21 Jul 2025)

Concord Drugs Limited (538965) to Launch New Product Line ✌️【Stock Buzz】✌️ Our trading intelligence platform has helped members turn small...

Quarterly Table

Standalone Consolidated

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	13.5	11.5	8.8	7.4	12.6	14.5	6.4	11.8	10.8	0.8
Expenses	12.1	10.8	7.4	5.9	12.1	14.3	5.6	11.0	9.5	7.0
Operating Profit	1.4	0.7	1.4	1.5	0.6	0.2	0.7	0.8	1.3	-6.2
OPM %	10.67%	6.42%	15.91%	20.7%	4.44%	1.29%	11.51%	6.7%	12.2%	-780.35%
Other Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5
Depreciation	0.4	0.3	0.4	0.4	0.4	0.4	0.3	0.3	0.4	0.4
Profit before tax	0.6	0.0	0.6	0.8	-0.3	-0.6	0.0	0.1	0.5	-7.1
Tax %	-26.3%	305.9%	-22.7%	-30.9%	-6.3%	-38.9%	-55.6%	-27%	-57.4%	0%
Net Profit	0.5	0.1	0.5	0.5	-0.2	-0.4	0.0	0.1	0.2	-7.2
EPS in Rs	0.52	0.07	0.52	0.56	-0.24	-0.35	0.01	0.05	0.22	0

Metrics	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	12.3	9.0	7.5	12.8	15.6	11.7	12.4	10.8	10.4
Expenses	11.3	7.5	5.9	12.2	15.3	10.9	11.5	9.4	9.3
Operating Profit	1.0	1.5	1.6	0.6	0.3	0.8	0.9	1.4	1.1
OPM %	7.87%	16.24%	21.35%	4.92%	2.23%	7.12%	7.01%	12.9%	10.4%
Other Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest	0.5	0.4	0.4	0.5	0.5	0.5	0.5	0.5	0.6
Depreciation	0.3	0.4	0.4	0.4	0.4	0.3	0.3	0.4	0.4
Profit before tax	0.1	0.6	0.8	-0.3	-0.5	0.0	0.1	0.5	0.1
Tax %	15.6%	-22.8%	-29.6%	-6.2%	-38.2%	-34.1%	-33.3%	-56.9%	0%
Net Profit	0.2	0.5	0.6	-0.2	-0.3	0.0	0.0	0.2	0.0
EPS in Rs	0.18	0.53	0.6	-0.24	-0.34	0.03	0.04	0.23	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	2%
5 Years:	-2%
3 Years:	-6%
TTM:	8%

Compounded Profit Growth
10 Years:	2%
5 Years:	0%
3 Years:	2%
TTM:	-108%

Stock Price CAGR
10 Years:	-7%
5 Years:	15%
3 Years:	6%
1 Year:	-20%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	21%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	-104%

Stock Price CAGR
10 Years:	-7%
5 Years:	15%
3 Years:	6%
1 Year:	-20%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Concord Drugs

Concord Drugs

Concord Drugs - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About Concord Drugs

Latest News

Concord Drugs Limited (538965) vs yyy - Unprecedented market success

Concord Drugs Limited (538965) to Launch New Product Line - Free Bull & Bear Market Updates

Where Could Concord Drugs Limited (538965) Be Headed - Exponential wealth increase

Concord Drugs Limited (538965) Hits 52 Week High - Market-beating returns

Can Concord Drugs Limited (538965) Maintain Its Valuation - Superior risk-adjusted returns

Concord Drugs Limited (538965) to Launch New Product Line - Free Wealth Planning Blueprint

Concord Drugs Adjusts Valuation Amid Mixed Financial Performance and Market Signals

CONCORD DRUGS Share Price Today Up 20%

Concord Drugs Faces Valuation Shift Amid Mixed Financial Indicators and Market Challenges

Concord Drugs Faces Mixed Technical Trends Amid Declining Financial Performance

Concord Drugs Faces Technical Shift Amidst Declining Performance and Valuation Opportunities

Heranba Industries reports consolidated net loss of Rs 41.49 crore in the March 2025 quarter

Stocks to Watch Today: ITC, Sun Pharma, IndusInd Bank, Honasa Consumer, MTAR Tech, Metro Brands, Power Mech, Bharat Electronics in focus on 23 May

Concord Drugs Adjusts Valuation Amid Mixed Performance and Market Challenges

Concord Drugs Standalone March 2025 Net Sales at Rs 7.96 crore, down 44.95% Y-o-Y

Concord Drugs Reports Mixed Financial Results Amid Sales Decline in May 2025

Concord Drugs reports consolidated net profit of Rs 0.04 crore in the March 2025 quarter

Q4 Results Highlights: GNFC profit rises 65% YoY; JSW Steel beats profit estimates

Camlin Fine Sciences reports consolidated net loss of Rs 0.72 crore in the March 2025 quarter

Q4 Results 2025 Today: Ashok Leyland, BEML, JSW Steel Among 200+ Companies To Declare Earnings On May 23

Q4 Results 2025: Over 700 Companies To Declare Earnings This Week, Full List Here

Q4 results: Bharat Electronics, DLF, IRB Infra, Jupiter Wagons, Indigo, IndusInd Bank, EIH Hotels, Power Grid among 700 companies to announce results this week

Q4 Results Next Week: ITC, Hindalco, Pfizer, Power Grid, IndusInd Bank, RVNL, JSW Steel, And More

Pharmaceutical Pellets Market Sees Rapid Expansion Fueled

Concord Biotech gets US FDA nod for marketing multiple sclerosis drug Teriflunomide

Certain medicines with misleading claims seized in Telangana

Schaeffler India, Blue Star, Concord Biotech: Second-rung stocks outperform large caps; BSE SmallCap index up 1%

Volumes jump at Ramkrishna Forgings Ltd counter

Live market news, research and portfolio

Concord Drugs Standalone December 2024 Net Sales at Rs 10.77 crore, down 14.66% Y-o-Y

Concord Drugs reports consolidated net profit of Rs 0.23 crore in the December 2024 quarter

Concord Drugs Reports Flat Q3 Results for FY 2024-25 Amid Mixed Financial Metrics

Sobha Ltd Slips 2.57%, BSE Realty index Shed 1.84%

Biocon surges after Malaysian facility gets classified as VAI by the US FDA

Q3 Results: TCS, IREDA, DMart, JustDial Among Companies To Announce Earnings This Week

Stocks To Watch: Adani Wilmar, TCS, Tata Elxsi, Mahanagar Gas, IREDA, And Others- News18

Concord Drugs Receives 'Hold' Rating After 64.28% Sales Growth in Q3 2024

MarketsMOJO Downgrades Concord Drugs to 'Sell' Rating Due to Weak Fundamentals

Opinion: A holiday wish: Congress must pass PBM reform

Concord Drugs Receives 'Hold' Rating and Shows Positive Growth, But Long-Term Fundamentals Remain Weak

CONCORD DRUGS Share Price Today Up 9%

Concord Drugs Consolidated September 2024 Net Sales at Rs 12.36 crore, up 64.44% Y-o-Y

Three stocks hit the circuits today: 63 Moons Technologies, Kitex Garments and Akums Drugs & Pharmaceuticals hit the upper circuit

Manchester Felon Arrested On Cocaine, Stolen Van Charges In Concord

Concord Drugs Standalone September 2024 Net Sales at Rs 11.84 crore, up 60.4% Y-o-Y

Concord Man Pleads Guilty To Gun, Drug Charges In U.S. District Court

NBCC, Deepak Nitrite, Eicher Motors, Patel Engineering Among 650+ Companies To Declare Q2 Results Today

650 Companies To Declare Q2 Results, Including Godrej Industries, Eicher Motors, AstraZeneca & Garden Reach Shipbuilders

Pharmaceutical Pellets Market Expected to Reach $4.41 Billion by 2031, Driven by Rising Demand for Chronic ...

New rules for US national security agencies balance AI’s promise with need to protect against risks

Biden, Sanders tout prescription drug cost-savings at NH event

Biden says global leaders are terrified of Trump quietly tell him, ‘He can’t win’

Biden says global leaders are terrified of Trump and quietly tell him, ‘He can’t win’

Massachusetts Woman Arrested On Another Drug Charge: Concord Cop Log

Pharmaceutical Pellets Market Scope and Latest Trends Analysis

Letter: Drugs are on the ballot

Pharmaceutical Pellets Market Advancements Highlighted by Size, Share, Global Analysis And Forecast To 2033

Eli Lilly’s Parenteral Product and Device Manufacturing Facility, Concord, North Carolina, US

Concord man arrested with 100 pounds of meth in van

Pharmaceutical Pellets Market Set for Strong Growth, Projected to Reach $4.41 Billion by 2031

PE firm Quadria Capital set to deploy around $1 billion in Indian market

Mass. Woman Arrested On DUI Charge After Crashing Jeep In Concord

Concord Drugs Consolidated June 2024 Net Sales at Rs 11.69 crore, up 30.19% Y-o-Y

Mass. Teen Arrested On Felony Drug, Alcohol Charges: Concord Cop Log

Concord Drugs Standalone June 2024 Net Sales at Rs 6.35 crore, down 27.71% Y-o-Y

Concord Drugs consolidated net profit declines 93.88% in the June 2024 quarter

Concord Drugs' Quarterly Financial Results Show Negative Trend, Lowest Operating Profit in 5 Quarters

Q1 Results, Aug 9: SJVN, IRB Infra, Siemens, Inox Wind To Declare Earnings Today

Q1 results today: India Cements, Inox, Siemens, Matrimony, Rupa, Bajaj Consumer Care, Grasim & more to report earnings | Company Business News

Q1 results today: India Cements, Inox, Siemens, Matrimony, Rupa, Bajaj Consumer Care, Grasim & more to report earnings

Stock market today: Akums Drugs share price extends gain after positive debut on Dalal Street. Buy, sell or hold? | Stock Market News